Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological
practice and research. Although most reviews are invited, the editors welcome suggestions from potential authors. They should first write
a brief outline of an intended review and send this to Dr Trevor Baglin or to Dr Jacob M. Rowe.
Authorship
All authors
should have made substantial contributions to all of the following: (1) the acquisition of data, or analysis and interpretation of data,
(2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Acknowledgements
All contributors who do not meet the criteria for authorship as defined above should be listed in an
acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance,
or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify
the entity that paid for this assistance.
Conflict of interest
At the end of the text, under a subheading "Conflict
of interest statement" all authors must disclose any financial and personal relationships with other people or organisations that
could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock
ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Role of the funding
source
All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role
of study sponsors, if any, in the collection, analysis and interpretation of data and in the writing of the manuscript. If the study
sponsors had no such involvement, the authors should so state.
Copyright
Upon acceptance of an article, authors will
be asked to sign a "Journal Publishing Agreement" (for more information on this and copyright see http://www.elsevier.com/wps/find/supportfaq.cws_home/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding
author confirming receipt of the manuscript together with a "Journal Publishing Agreement" form.
If excerpts from other
copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the
article. Elsevier has preprinted forms for use by authors in these cases : contact Elsevier's Rights Department, Philadelphia, PA, USA:
Tel. (+1) 215 238 7869; Fax (+1) 215 238 2239; e-mail healthpermissions@elsevier.com . Requests may also be completed
online via the Elsevier homepage (http://www.elsevier.com/locate/permissions).
Funding body agreements and policies Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with potential
manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies
please visit http://www.elsevier.com/fundingbodies
Proofs
One set of page proofs in PDF format will be sent
by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post). Elsevier now sends
PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from http://www.adobe.com/products/acrobat/readstep2.html.
Instructions on how to annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail,
or by post.
Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor.
We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of
your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article
if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article
via e-mail. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and
a disclaimer outlining the terms and conditions of use.
This journal and
the individual contributions contained in it are protected under copyright by Elsevier Ltd, and the following terms and conditions apply
to their use:
Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright
laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying,
copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational
institutions that wish to make photocopies for non-profit educational classroom use.
For information on how to seek permission visit
www.elsevier.com/permissions or call: (+44) 1865 843830 (UK) / (+1) 215 239 3804 (USA).
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions.
Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for
all other derivative works, including compilations and translations (please consult www.elsevier.com/permissions).
Electronic
Storage or Usage
Permission of the Publisher is required to store or use electronically any material contained in this journal,
including any article or part of an article (please consult www.elsevier.com/permissions). Except as outlined above, no
part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical,
photocopying, recording or otherwise, without prior written permission of the Publisher.
Notice No responsibility is assumed
by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from
any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the
medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material
is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of
the quality or value of such product or of the claims made of it by its manufacturer.
